| 10428034 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Adam Matthew Gilbert, Christopher John Helal +6 more |
2019-10-01 |
| 10421744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2019-09-24 |
| 10329308 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Christopher John Helal, Steven Victor O'Neil, Patrick Robert Verhoest |
2019-06-25 |
| 10316021 |
Heteroarylphenoxy benzamide kappa opioid ligands |
Natasha Mariam Kablaoui, Michael Eric Green, Justin Ian Montgomery, Patrick Robert Verhoest, Gregory Wayne Kauffman +5 more |
2019-06-11 |
| 10253042 |
N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]oxazin-8a(8H)-YL)-thiazol-4-YL) amides |
Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill |
2019-04-09 |
